RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RRBP1 rewires cisplatin resistance in oral squamous cell carcinoma by regulating Hippo pathway
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-24
DOI
10.1038/s41416-021-01336-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
- (2020) Omprakash Shriwas et al. APOPTOSIS
- RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
- (2019) Shuang Liu et al. Diagnostic Pathology
- Analysis of the role of the Hippo pathway in cancer
- (2019) Yanyan Han Journal of Translational Medicine
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- RRBP1 is highly expressed in prostate cancer and correlates with prognosis
- (2019) Tieqiu Li et al. Cancer Management and Research
- Expression of RRBP1 in epithelial ovarian cancer and its clinical significance
- (2019) Jing Ma et al. BIOSCIENCE REPORTS
- Serum Small Extracellular Vesicles Proteome of Tuberculosis Patients Demonstrated Deregulated Immune Response
- (2019) Rakesh Arya et al. Proteomics Clinical Applications
- Expression and significance of RRBP1 in esophageal carcinoma
- (2018) Liang Wang et al. Cancer Management and Research
- The Hippo Signaling Network and its Biological Functions
- (2018) Jyoti R. Misra et al. Annual Review of Genetics
- STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma
- (2018) Santanu Maji et al. CARCINOGENESIS
- Hippo pathway mediates resistance to cytotoxic drugs
- (2017) Taranjit S. Gujral et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation
- (2017) Victoria Hung et al. eLife
- Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis
- (2015) Y Pan et al. BRITISH JOURNAL OF CANCER
- Mcl-1 is an important therapeutic target for oral squamous cell carcinomas
- (2015) Santanu Maji et al. Oncotarget
- Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer
- (2015) Sabindra K. Samal et al. Scientific Reports
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
- (2014) Martina McDermott et al. Frontiers in Oncology
- Endoplasmic reticulum ribosome-binding protein 1 (RRBP1) overexpression is frequently found in lung cancer patients and alleviates intracellular stress-induced apoptosis through the enhancement of GRP78
- (2013) H-Y Tsai et al. ONCOGENE
- Oral cancer: Current role of radiotherapy and chemotherapy
- (2013) SH. Huang et al. Medicina Oral Patologia Oral y Cirugia Bucal
- Cancer mortality in India: a nationally representative survey
- (2012) Rajesh Dikshit et al. LANCET
- Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer
- (2011) Annemieke H. Ackerstaff et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Enhancement of Procollagen Biosynthesis by p180 through Augmented Ribosome Association on the Endoplasmic Reticulum in Response to Stimulated Secretion
- (2010) Tomonori Ueno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started